View Author
Pareren, Y. van
( Y. van Pareren)
gh treatment group treatment children height puberty growth level pubertal height gain group b study height sds onset insulin discontinuation 6 months gh dosage groups endocrinol pubertal control difference control group metab gh dose month effect menarche glucose result hormone adult height score sga children gh-dosage groups adult catch-up growth dosage duration growth hormone bmi sd score trial value interval bone age delay insulin levels serum lipid levels birth table bone age fasting atherogenic index 30- min ratio muinck keizer-schrama sm blood pressure gh therapy downloaded november ratio dutch reference tanner gh-treated lipid gh-dosage fasting insulin levels serum child growth hormone treatment change patient risk factors 0.3 netherland adolescent range factor pareren variable blood catch-up
3 Most Recent Publications
|
Effect of discontinuation of growth hormone treatment on risk factors for cardiovascular disease in adolescents born small for gestational age
(Article)
Pareren, Y. van Houdijk, M. Jansen, M. Reeser, M. Mulder, P.G.H. Hokken-Koelega, A.C.S. |
2003-01-01
|
|
Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial
(Article)
Pareren, Y. van Houdijk, M. Jansen, M. Reeser, M. Mulder, P.G.H. Hokken-Koelega, A.C.S. |
2003-01-01
|
|
Puberty in growth hormone-treated children born small for gestational age (SGA)
(Article)
Boonstra, V.H. Pareren, Y. van Mulder, P.G.H. Hokken-Koelega, A.C.S. |
2003-01-01
|